Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7345 p442
16 April 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Diet unlikely to affect most patients’ medicines

The risk of interactions between food and medicines is real, but not of great clinical significance for most people, members of the Committee on the Safety of Medicines and the Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment decided at a recent meeting of the two organisations.

In a working paper on diet and drug interactions, the committees recommend that, for patients stabilised on a particular drug, the most appropriate practical advice is to leave their diet unchanged. They also argue that there is no need for a widespread public information campaign about food-drug interactions, but that practitioners and prescribers should be aware of potential drug-food interactions and should consider them both when prescribing and when a lack of efficacy, or unexpected toxicity, occurs.

The committees argue that children and the elderly may be more vulnerable to the effects of drug and food interactions and that the risk of such interactions may be highest in individuals taking multiple medicines or medicines with a narrow therapeutic index. However, to assess the significance of individual reactions, the likely consumption of food and drugs and the likely severity of any possible reaction need to be considered.

Back to Top


©The Pharmaceutical Journal